Literature DB >> 10599815

Suppression of pendular nystagmus by smoking cannabis in a patient with multiple sclerosis.

F Schon1, P E Hart, T L Hodgson, A L Pambakian, M Ruprah, E M Williamson, C Kennard.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10599815     DOI： 10.1212/wnl.53.9.2209-a

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  14 in total

Review 1.  Medical treatment of nystagmus and its visual consequences.

Authors:  John S Stahl; Gordon T Plant; R John Leigh
Journal:  J R Soc Med       Date:  2002-05       Impact factor: 5.344

Review 2.  Cannabinoids in clinical practice.

Authors:  E M Williamson; F J Evans
Journal:  Drugs       Date:  2000-12       Impact factor: 9.546

Review 3.  The endocannabinoid system as an emerging target of pharmacotherapy.

Authors:  Pál Pacher; Sándor Bátkai; George Kunos
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

4.  Medicinal marijuana use: experiences of people with multiple sclerosis.

Authors:  Stacey A Page; Marja J Verhoef
Journal:  Can Fam Physician       Date:  2006-01       Impact factor: 3.275

Review 5.  [Therapeutic use of cannabinoids in neurology].

Authors:  P Schwenkreis; M Tegenthoff
Journal:  Schmerz       Date:  2003-10       Impact factor: 1.107

Review 6.  Cannabinoids and multiple sclerosis.

Authors:  Roger G Pertwee
Journal:  Mol Neurobiol       Date:  2007-06-26       Impact factor: 5.590

Review 7.  Cannabinoids in multiple sclerosis: do they have a therapeutic role?

Authors:  Joep Killestein; Bernard M J Uitdehaag; Chris H Polman
Journal:  Drugs       Date:  2004       Impact factor: 9.546

8.  Acquired pendular nystagmus in multiple sclerosis: an examiner-blind cross-over treatment study of memantine and gabapentin.

Authors:  Michaela Starck; Holger Albrecht; Walter Pöllmann; Marianne Dieterich; Andreas Straube
Journal:  J Neurol       Date:  2009-09-13       Impact factor: 4.849

Review 9.  [New aspects of symptomatic MS treatment: Part 4-sexual dysfunction and eye movement disorders].

Authors:  T Henze; W Feneberg; P Flachenecker; D Seidel; H Albrecht; M Starck; S G Meuth
Journal:  Nervenarzt       Date:  2018-02       Impact factor: 1.214

10.  The effects of gabapentin and memantine in acquired and congenital nystagmus: a retrospective study.

Authors:  T Shery; F A Proudlock; N Sarvananthan; R J McLean; I Gottlob
Journal:  Br J Ophthalmol       Date:  2006-03-23       Impact factor: 4.638
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.